BIOMARKER:

VHL mutation

Entrez ID:

Related biomarkers:

‹

›

VHL mutation VHL mutation	Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma	MK-6482 Sensitive: C2 – Inclusion Criteria
VHL mutation VHL mutation	Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma	PT2385 Sensitive: C2 – Inclusion Criteria
VHL mutation VHL mutation	Neuroendocrine Tumor Neuroendocrine Tumor	PT2385 Sensitive: C3 – Early Trials
VHL mutation VHL mutation	Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma	pazopanib Resistant: C3 – Early Trials
VHL mutation VHL mutation	Renal Cell Carcinoma RCC	everolimus Sensitive: C3 – Early Trials
VHL mutation VHL mutation	Glioblastoma GBM	MK-6482 Sensitive: C3 – Early Trials
VHL mutation VHL mutation	Neuroendocrine Tumor Neuroendocrine Tumor	MK-6482 Sensitive: C3 – Early Trials
VHL mutation VHL mutation	Cholangiocarcinoma Cholangiocarcinoma	sunitinib Sensitive: C4 – Case Studies
VHL mutation VHL mutation	Renal Cell Carcinoma RCC	doxorubicin hydrochloride Sensitive: D – Preclinical